POLY MEDICURE Financial Statement Analysis
|
||
|
The Revenues of POLY MEDICURE have increased by 23.36% YoY .
The Earnings Per Share (EPS) of POLY MEDICURE has increased by 24.15 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
POLY MEDICURE Last 5 Annual Financial Results
[BOM: 531768|NSE : POLYMED]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹1,376 Cr | ₹1,115 Cr | ₹923 Cr | ₹786 Cr | ₹687 Cr |
| Expenses | ₹1,016 Cr | ₹848 Cr | ₹708 Cr | ₹570 Cr | ₹521 Cr |
| Operating Profit (Excl OI) | ₹360 Cr | ₹267 Cr | ₹215 Cr | ₹216 Cr | ₹166 Cr |
| Other Income | ₹59 Cr | ₹36 Cr | ₹38 Cr | ₹18 Cr | ₹18 Cr |
| Interest | ₹14 Cr | ₹11 Cr | ₹6.16 Cr | ₹11 Cr | ₹20 Cr |
| Depreciation | ₹63 Cr | ₹57 Cr | ₹54 Cr | ₹48 Cr | ₹41 Cr |
| Profit Before Tax | ₹344 Cr | ₹237 Cr | ₹195 Cr | ₹180 Cr | ₹126 Cr |
| Profit After Tax | ₹258 Cr | ₹179 Cr | ₹147 Cr | ₹136 Cr | ₹96 Cr |
| Consolidated Net Profit | ₹258 Cr | ₹179 Cr | ₹147 Cr | ₹136 Cr | ₹96 Cr |
| Earnings Per Share (Rs) | ₹33.41 | ₹26.91 | ₹18.69 | ₹15.28 | ₹14.17 |
| PAT Margin (%) | 20.19 | 18.70 | 16.01 | 15.80 | 17.19 |
| ROE(%) | 16.01 | 19.09 | 15.42 | 14.29 | 19.42 |
| ROCE(%) | 20.37 | 23.63 | 19.10 | 17.42 | 21.96 |
| Total Debt/Equity(x) | 0.06 | 0.12 | 0.12 | 0.12 | 0.14 |
Key Financials |
||
| Market Cap | : | ₹ 20,263.8 Cr |
| Revenue (TTM) | : | ₹ 1,688.3 Cr |
| Net Profit(TTM) | : | ₹ 351.5 Cr |
| EPS (TTM) | : | ₹ 34.7 |
| P/E (TTM) | : | 57.6 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| POLY MEDICURE | 5.1% | 2.7% | -24.8% |
| NURECA | -15.7% | 15.3% | -2.7% |
POLY MEDICURE Revenues
[BOM: 531768|NSE : POLYMED]
| Y-o-Y | 23.36 % |
| 5 Yr CAGR | 18.95 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,376 Cr | 23.36 | |
| Mar2024 | ₹1,115 Cr | 20.82 | |
| Mar2023 | ₹923 Cr | 17.37 | |
| Mar2022 | ₹786 Cr | 14.44 | |
| Mar2021 | ₹687 Cr | - | |
POLY MEDICURE Operating Profit
[BOM: 531768|NSE : POLYMED]
| Y-o-Y | 34.63 % |
| 5 Yr CAGR | 21.33 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹360 Cr | 34.63 | |
| Mar2024 | ₹267 Cr | 24.37 | |
| Mar2023 | ₹215 Cr | -0.68 | |
| Mar2022 | ₹216 Cr | 30.32 | |
| Mar2021 | ₹166 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 9.13 % |
| 5 Yr CAGR | 2.01 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 26.17% | 9.13 | |
| Mar2024 | 23.98% | 2.96 | |
| Mar2023 | 23.29% | -15.40 | |
| Mar2022 | 27.53% | 13.90 | |
| Mar2021 | 24.17% | - | |
POLY MEDICURE Profit After Tax
[BOM: 531768|NSE : POLYMED]
| Y-o-Y | 44.05 % |
| 5 Yr CAGR | 28.11 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹258 Cr | 44.05 | |
| Mar2024 | ₹179 Cr | 22.37 | |
| Mar2023 | ₹147 Cr | 7.82 | |
| Mar2022 | ₹136 Cr | 41.72 | |
| Mar2021 | ₹96 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 7.97 % |
| 5 Yr CAGR | 4.10 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 20.19 % | 7.97 | |
| Mar2024 | 18.7 % | 16.80 | |
| Mar2023 | 16.01 % | 1.33 | |
| Mar2022 | 15.8 % | -8.09 | |
| Mar2021 | 17.19 % | - | |
POLY MEDICURE Earnings Per Share (EPS)
[BOM: 531768|NSE : POLYMED]
| Y-o-Y | 24.15 % |
| 5 Yr CAGR | 23.92 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹33 | 24.15 | |
| Mar2024 | ₹27 | 43.98 | |
| Mar2023 | ₹19 | 22.32 | |
| Mar2022 | ₹15 | 7.83 | |
| Mar2021 | ₹14 | - | |
POLY MEDICURE Return on Capital Employed (ROCE)
[BOM: 531768|NSE : POLYMED]
| Y-o-Y | -13.80 % |
| 5 Yr CAGR | -1.86 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 20.37% | -13.80 | |
| Mar2024 | 23.63% | 23.72 | |
| Mar2023 | 19.1% | 9.64 | |
| Mar2022 | 17.42% | -20.67 | |
| Mar2021 | 21.96% | - | |
POLY MEDICURE Share Price vs Sensex
| Current Share Price | : | ₹1,998.4 |
| Current MarketCap | : | ₹ 20,263.8 Cr |
| Updated EOD on | : | Oct 31,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| POLY MEDICURE | 5.1% |
2.7% |
-24.8% |
| SENSEX | -0.3% |
4.5% |
5.7% |
POLY MEDICURE related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE 500 SHARIAH | 4.3% | 4.3% | 1.1% |
| BSE SMALLCAP | 0.7% | 3.2% | 2.9% |
| BSE 400 MIDSMALLCAP INDEX | 0.7% | 4.1% | 3.4% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY SMALLCAP250 MOMENTUM QUALITY 100 INDEX | 0.8% | 3.2% | -5.5% |
| NIFTY MIDSMALLCAP 400 | 0.7% | 4.5% | 5.4% |
| NIFTY SMALLCAP 250 | 0.6% | 3.9% | 2.1% |
| NIFTY 500 EQUAL WEIGHT | 0.5% | 3.5% | 4.9% |
| NIFTY MIDSMALLCAP400 MOMENTUM QUALITY 100 INDEX | 0.5% | 3.7% | -3.2% |
You may also like the below Video Courses
FAQ about POLY MEDICURE Financials
How the annual revenues of POLY MEDICURE have changed ?
The Revenues of POLY MEDICURE have increased by 23.36% YoY .
How the Earnings per Share (EPS) of POLY MEDICURE have changed?
The Earnings Per Share (EPS) of POLY MEDICURE has increased by 24.15 % YoY .
Check out Intrinsic Value of Peers of POLY MEDICURE
|
Intrinsic Value of POLY MEDICURE LTD Intrinsic Value of NURECA LTD |
